Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.407EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.423EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.281EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.230EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.535EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.564.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.345EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.450EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.334EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.589EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.335EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.169EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.442EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.106EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
D.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.593EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.513EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.338EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.284EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.498EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.184EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.187EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
D.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.342EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.500EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.511EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.506EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.482EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.335EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.499.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.116EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.393EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.381EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used